|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00911 QIANHAI HEALTH
Nominal 
0.320 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 961,291 | -50.997% | 1,961,704 | 283,398 | 760,721 | 587,808 |
| Cost of Sales | (996,894) | -47.121% | (1,885,222) | (267,360) | (715,593) | (555,125) |
| Gross Profit | (35,603) | -- | 76,482 | 16,038 | 45,128 | 32,683 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (1,639) | (1,388) | |
| Profit / (Loss) before Taxation | (52,705) | -77.448% | (233,703) | (888) | (804) | 26,715 | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (52,705) | -77.448% | (233,703) | (888) | (804) | 26,715 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (26) | -60.606% | (66) | 389 | 1,633 | (16,335) |
| Depreciation & Amortisation | 2,433 | -0.041% | 2,434 | 2,436 | 3,024 | 2,408 |
| Directors' Emoluments | 1,335 | -49.604% | 2,649 | 4,268 | 5,471 | 2,116 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Qualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -31.100 | -77.447% | -137.900 | -0.500 | -0.500 | 15.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.005 | -- | (0.031) | (0.026) | (0.042) | (0.224) |
| NBV per share ($) | 2.267 | -- | 2.577 | 3.957231 | 3.976854 | 3.913213 |
| Remarks: | Real time quote last updated: 18/11/2024 12:17 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 15,548,000 |
| %Change | -- |
| EPS / (LPS) | HKD 0.092 |
| NBV Per Share ($) | HKD 2.360 |